Fundamental dimension Equity attribute | CHDNLeader $83.73▼-0.85% Cap $5.84BP/E 14.3x QuantScore60/100 | BALYPeer $13.86▲+0.73% Cap $588.5MP/E -1.1x QuantScore33/100 | BYDPeer $71.69▼-0.80% Cap $5.21BP/E 10.8x QuantScore54/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
73/100 |
65/100 |
61/100 |
Valuation Multiples, PEG & DCF upside | 96/100 | 48/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 21/100 | 8/100 | 28/100 |
Growth Revenue / earnings growth & margins | 26/100 | 27/100 | 31/100 |
Sentiment Analyst ratings, targets & revisions | 83/100 | 17/100 | 74/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 14.3x | -1.1x | 10.8x |
Forward P/E (next FY) | 12.3x | -1.7x | 10.0x |
EV / EBITDA (TTM) | 9.3x | 10.8x | 7.4x |
Price / Sales | 2.0x | 0.2x | 1.3x |
Price / Free Cash Flow | 15.3x | -1.2x | 148.5x |
PEG ratio | -28.05 | 0.34 | -0.15 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 4 / 9 | 6 / 9 |
Altman Z-Score | 1.47 (Distress) | 0.12 (Distress) | 2.22 (Grey) |
Total debt / equity | 3.57 | 3.58 | 1.30 |
Quick ratio | 0.3x | 0.8x | 0.7x |
Interest coverage | 2.5x | -0.1x | 7.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +7.0% | +8.4% | +4.1% |
Net income growth YoY | -11.0% | -23.5% | +218.9% |
Gross margin (TTM) | 37.2% | 31.8% | 30.0% |
Operating margin (FY) | 25.2% | 1.1% | 21.4% |
FCF margin (FY) | 10.6% | -10.4% | 9.5% |
5. Trailing price performancePrice change over period |
1M return | +5.4% | -1.4% | -0.2% |
3M return | -3.2% | +1.0% | -17.6% |
6M return | -17.5% | +9.3% | -14.5% |
Year to date | -26.4% | -16.1% | -15.9% |
1Y return | -17.1% | -27.5% | -9.0% |
3Y return | -24.9% | +60.2% | +17.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $158.42 +89.2% upside | $-21.05 -251.9% premium | $411.75 +474.3% upside |
Wall Street consensus target | $131.67 +57.3% · range $119.00–$145.00 | $10.25 -26.0% · range $7.00–$13.00 | $87.70 +22.3% · range $80.00–$103.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 8% Buy83% Hold8% Sell | 64% Buy36% Hold0% Sell |